{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:35:20Z","timestamp":1792506920775,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000143","name":"Alzheimer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009271","name":"Canadian Nurses Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008914","name":"Ontario Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CNA-137794"],"award-info":[{"award-number":["CNA-137794"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CNA-163902"],"award-info":[{"award-number":["CNA-163902"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["BDO-148341"],"award-info":[{"award-number":["BDO-148341"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000194","name":"Nova Scotia Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013333","name":"Hypertension Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.tjpad.2025.100068","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:12:32Z","timestamp":1738325552000},"page":"100068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3956-1668","authenticated-orcid":false,"given":"Eric E.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-4538","authenticated-orcid":false,"given":"Howard H.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Borrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-2070","authenticated-orcid":false,"given":"Aravind","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-0860","authenticated-orcid":false,"given":"Alexandre","family":"Henri-Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Desmarais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3971-5920","authenticated-orcid":false,"given":"Andrew","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmanPreet","family":"Badhwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1274-8956","authenticated-orcid":false,"given":"Laura","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-9011","authenticated-orcid":false,"given":"Jennifer","family":"Bethell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Bhangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2631-1387","authenticated-orcid":false,"given":"Christian","family":"Bocti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-0655","authenticated-orcid":false,"given":"Susan E.","family":"Bronskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9888-008X","authenticated-orcid":false,"given":"Amer M.","family":"Burhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4203-0887","authenticated-orcid":false,"given":"Frederic","family":"Calon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-8660","authenticated-orcid":false,"given":"Richard","family":"Camicioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8432-7021","authenticated-orcid":false,"given":"D. Louis","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-2672","authenticated-orcid":false,"given":"Mahsa","family":"Dadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9281-9547","authenticated-orcid":false,"given":"Mari L.","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-1113","authenticated-orcid":false,"given":"Simon","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-0745","authenticated-orcid":false,"given":"Simon","family":"Duchesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0770-5471","authenticated-orcid":false,"given":"Gillian","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-7517","authenticated-orcid":false,"given":"Jodie R.","family":"Gawryluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Itzhak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6400-8701","authenticated-orcid":false,"given":"Manish","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5653-3979","authenticated-orcid":false,"given":"Edeltraut","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-353X","authenticated-orcid":false,"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Laforce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-6637","authenticated-orcid":false,"given":"Krista L.","family":"Lanctot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9774-9568","authenticated-orcid":false,"given":"Linda","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Masellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Massoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara B.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5796-2361","authenticated-orcid":false,"given":"Manuel","family":"Montero-Odasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Myers Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5085-4723","authenticated-orcid":false,"given":"Haakon B.","family":"Nygaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Natasha","family":"Rajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5765-4927","authenticated-orcid":false,"given":"Julie M.","family":"Robillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Rockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas P.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-4437","authenticated-orcid":false,"given":"Shanna C.","family":"Trenaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aicha","family":"Zadem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Chertkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100068_bib0001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.tjpad.2025.100068_bib0002","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/alzrt201","article-title":"Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian consensus conference on the diagnosis and treatment of dementia 2012","volume":"5","author":"Herrmann","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100068_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100068_bib0004","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100068_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prevent Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100068_bib0006","series-title":"Assessing the preparedness of the Canadian health care system infrastructure for an Alzheimer\u2019s treatment","author":"Liu","year":"2019"},{"key":"10.1016\/j.tjpad.2025.100068_bib0007","first-page":"1","article-title":"A model predicting healthcare capacity gaps for Alzheimer's disease-modifying treatment in Canada","author":"Black","year":"2023","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100068_bib0008","doi-asserted-by":"crossref","first-page":"E1446","DOI":"10.1503\/cmaj.230595","article-title":"Disease-modifying drugs for Alzheimer disease: implications for people in Canada","volume":"195","author":"Watt","year":"2023","journal-title":"CMAJ"},{"key":"10.1016\/j.tjpad.2025.100068_bib0009","first-page":"1","article-title":"Health system change for Alzheimer's disease-modifying therapies in Canada: beginning the discussion","author":"Frank","year":"2023","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100068_bib0010","article-title":"Understanding the portrait of dementia care in Canada: a CADTH panel of experts","volume":"2","author":"Varette","year":"2022","journal-title":"Can J Health Technol"},{"key":"10.1016\/j.tjpad.2025.100068_bib0011","first-page":"1","article-title":"Health system change for new therapies in Alzheimer's Disease: putting the cart before the horse?","author":"Bocti","year":"2024","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100068_bib0012","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/13872877241290990","article-title":"Impact of a national dementia research consortium: the Canadian Consortium on Neurodegeneration in Aging (CCNA)","volume":"102","author":"Chertkow","year":"2024","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.tjpad.2025.100068_bib0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40900-022-00359-5","article-title":"Engagement of people with lived experience of dementia advisory group and cross-cutting program: reflections on the first year","volume":"8","author":"Snowball","year":"2022","journal-title":"Res Involv Engag"},{"key":"10.1016\/j.tjpad.2025.100068_bib0014","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jclinepi.2016.01.002","article-title":"Extracting data from figures with software was faster, with higher interrater reliability than manual extraction","volume":"74","author":"Jelicic Kadic","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tjpad.2025.100068_bib0015","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100068_bib0016","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","article-title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","volume":"43","author":"Tucker","year":"2015","journal-title":"J Alzheimer's Dis: JAD"},{"key":"10.1016\/j.tjpad.2025.100068_bib0017","first-page":"227","article-title":"A combined measure of cognition and function for clinical trials: the Integrated Alzheimer's disease rating scale (iADRS)","volume":"2","author":"Wessels","year":"2015","journal-title":"J Prevent Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100068_bib0018","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer's disease mice","volume":"76","author":"Demattos","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.tjpad.2025.100068_bib0019","doi-asserted-by":"crossref","first-page":"771","DOI":"10.14283\/jpad.2023.123","article-title":"Lecanemab clarity AD: quality-of-life results from a randomized, double-blind phase 3 trial in early Alzheimer's disease","volume":"10","author":"Cohen","year":"2023","journal-title":"J Prevent Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100068_bib0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.7326\/M23-3377","article-title":"Talking with patients about the new anti-amyloid Alzheimer Disease medications","volume":"177","author":"Sarkisian","year":"2024","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.tjpad.2025.100068_bib0021","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/alz.13770","article-title":"Minimal clinically important difference in Alzheimer's disease: rapid review","volume":"20","author":"Muir","year":"2024","journal-title":"Alzheimer's Dement J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0022","doi-asserted-by":"crossref","first-page":"595","DOI":"10.14283\/jpad.2023.50","article-title":"'Time Saved' as a demonstration of clinical meaningfulness and illustrated using the donanemab TRAILBLAZER-ALZ study findings","volume":"10","author":"Dickson","year":"2023","journal-title":"J Prevent Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100068_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000054761","article-title":"Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials","volume":"20","author":"Rockwood","year":"2001","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tjpad.2025.100068_bib0024","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.2003.029074","article-title":"Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease","volume":"75","author":"Rockwood","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100068_bib0025","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jalz.2017.02.005","article-title":"Clinical meaningfulness of Alzheimer's Disease Assessment Scale-cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors","volume":"13","author":"Rockwood","year":"2017","journal-title":"Alzheimer's Dement J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0026","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12913-023-09100-8","article-title":"Rural and urban differences in quality of dementia care of persons with dementia and caregivers across all domains: a systematic review","volume":"23","author":"Arsenault-Lapierre","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.tjpad.2025.100068_bib0027","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MLR.0000000000001577","article-title":"Dementia diagnosis disparities by race and ethnicity","volume":"59","author":"Lin","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.tjpad.2025.100068_bib0028","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dement J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0029","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain : J Neurol"},{"key":"10.1016\/j.tjpad.2025.100068_bib0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prevent Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100068_bib0031","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2013.285063","article-title":"How to use a subgroup analysis: users' guide to the medical literature","volume":"311","author":"Sun","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100068_bib0032","article-title":"Scientists tie third clinical trial death to experimental Alzheimer\u2019s drug","author":"Piller","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tjpad.2025.100068_bib0033","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMc2215148","article-title":"Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke","volume":"388","author":"Reish","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100068_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WAD.0000000000000144","article-title":"Amyloid PET screening for enrichment of early-stage Alzheimer Disease clinical trials: experience in a phase 1b clinical trial","volume":"30","author":"Sevigny","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.tjpad.2025.100068_bib0035","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/alz.12105","article-title":"Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia","volume":"16","author":"Ismail","year":"2020","journal-title":"Alzheimer's Dement J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0036","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/cjn.2015.401","article-title":"Canadian Consensus Guidelines on use of amyloid imaging in Canada: update and future directions from the Specialized Task Force on amyloid imaging in Canada","volume":"43","author":"Laforce","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100068_bib0037","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s43441-022-00390-4","article-title":"Application of meta-analysis to evaluate relationships among ARIA-E rate, amyloid reduction rate, and clinical cognitive response in amyloid therapeutic clinical trials for early Alzheimer's disease","volume":"56","author":"Wang","year":"2022","journal-title":"Therapeut Innovat Regulat Sci"},{"key":"10.1016\/j.tjpad.2025.100068_bib0038","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI procedure Standard\/EANM practice guideline for Amyloid PET imaging of the brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.tjpad.2025.100068_bib0039","doi-asserted-by":"crossref","unstructured":"Chao Y.-.S., Sinclair A., Morrison A., Hafizi D., Pyke L. The Canadian Medical Imaging Inventory 2019\u20132020. 2022. PMID.","DOI":"10.51731\/cjht..24"},{"key":"10.1016\/j.tjpad.2025.100068_bib0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer's Disease: moving from CSF to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol Therapy"},{"key":"10.1016\/j.tjpad.2025.100068_bib0042","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jalz.2018.07.220","article-title":"Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease. Alzheimer's & dementia","volume":"14","author":"Shaw","year":"2018","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0043","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/alz.12545","article-title":"Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: an international overview","volume":"18","author":"Delaby","year":"2022","journal-title":"Alzheimer's Dement J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0044","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.tjpad.2025.100068_bib0046","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer Disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100068_bib0047","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13195-024-01513-9","article-title":"Diagnostic performance of plasma pTau(217), pTau(181), abeta(1-42) and abeta(1-40) in the LUMIPULSE automated platform for the detection of Alzheimer disease","volume":"16","author":"Arranz","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100068_bib0048","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/alz.13762","article-title":"Blood tests for Alzheimer's disease: the impact of disease prevalence on test performance","volume":"20","author":"DeMarco","year":"2024","journal-title":"Alzheimer's & Dement"},{"key":"10.1016\/j.tjpad.2025.100068_bib0049","article-title":"Udeh-Momoh CT. Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease","author":"Mielke","year":"2024","journal-title":"Alzheimer's Dement J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/cjn.2024.338","article-title":"Recommendations on imaging in the context of Alzheimer\u2019s disease modifying therapies from the CCNA Imaging Workgroup","author":"Duchesne","year":"2024","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100068_bib0052","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3174\/ajnr.A1355","article-title":"MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength","volume":"30","author":"Nandigam","year":"2009","journal-title":"AJNR. Am J Neuroradiol."},{"key":"10.1016\/j.tjpad.2025.100068_bib0053","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011146","article-title":"Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis","volume":"7","author":"Lang","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.tjpad.2025.100068_bib0054","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","article-title":"Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors","volume":"23","author":"Bradford","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.tjpad.2025.100068_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14283\/jpad.2023.131","article-title":"Detection rates of mild cognitive impairment in primary care for the United States Medicare population","volume":"11","author":"Liu","year":"2024","journal-title":"J Prevent Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100068_bib0056","first-page":"e12057","article-title":"CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales","volume":"6","author":"Tang-Wai","year":"2020","journal-title":"Alzheimer's Dement J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0057","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.9778\/cmajo.20190053","article-title":"Impact of the Quebec Alzheimer Plan on the detection and management of Alzheimer disease and other neurocognitive disorders in primary health care: a retrospective study","volume":"7","author":"Vedel","year":"2019","journal-title":"CMAJ Open"},{"key":"10.1016\/j.tjpad.2025.100068_bib0058","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/j.1532-5415.2010.03130.x","article-title":"Enhancing dementia care: a primary care-based memory clinic","volume":"58","author":"Lee","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0059","first-page":"307","article-title":"Primary care-based memory clinics: expanding capacity for dementia care","volume":"33","author":"Lee","year":"2014","journal-title":"Canadian journal on aging = La revue canadienne du vieillissement"},{"key":"10.1016\/j.tjpad.2025.100068_bib0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/jgs.15169","article-title":"Effect of primary care-based memory clinics on referrals to and wait-time for specialized geriatric services","volume":"66","author":"Lee","year":"2018","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.tjpad.2025.100068_bib0061","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/nmt-2018-0024","article-title":"Persons with dementia and care partners' perspectives on memory clinics in primary care","volume":"8","author":"Lee","year":"2018","journal-title":"Neurodegenerat Dis Manag"},{"key":"10.1016\/j.tjpad.2025.100068_bib0062","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064882","article-title":"Cost-utility analysis of a multispecialty interprofessional team dementia care model in Ontario, Canada","volume":"13","author":"Wong","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.tjpad.2025.100068_bib0063","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12939-024-02166-8","article-title":"Considering inequities in national dementia strategies: breadth, depth, and scope","volume":"23","author":"Godard-Sebillotte","year":"2024","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.tjpad.2025.100068_bib0064","first-page":"78","article-title":"Rural-urban differences in healthcare use in persons with dementia between 2000 and 2019: a Quebec population-based study","volume":"19","author":"Arsenault-Lapierre","year":"2024","journal-title":"Healthc Policy"},{"key":"10.1016\/j.tjpad.2025.100068_bib0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12913-024-10817-3","article-title":"Rural-urban differences in use of health services before and after dementia diagnosis: a retrospective cohort study","volume":"24","author":"Kosteniuk","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.tjpad.2025.100068_bib0066","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12913-024-11066-0","article-title":"Perceptions and outcomes of an embedded Alzheimer Society First Link Coordinator in rural primary health care memory clinics","volume":"24","author":"Morgan","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.tjpad.2025.100068_bib0076","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1503\/cmaj.141165","article-title":"Recommendations on screening for cognitive impairment in older adults","volume":"188","author":"Canadian Task Force on Preventive Health C","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.tjpad.2025.100068_bib0078","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/gps.2013","article-title":"Medical research council Cognitive F, Ageing S. Mild cognitive impairment in the older population: who is missed and does it matter?","volume":"23","author":"Stephan","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100068_bib0079","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jgs.16247","article-title":"Risks and benefits of screening for dementia in primary care: the Indiana University Cognitive Health Outcomes investigation of the comparative effectiveness of dementia screening (IU CHOICE) trial","volume":"68","author":"Fowler","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.tjpad.2025.100068_bib0068","doi-asserted-by":"crossref","first-page":"e1837","DOI":"10.1212\/WNL.0000000000207770","article-title":"Eligibility for anti-amyloid treatment in a population-based study of cognitive aging","volume":"101","author":"Pittock","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100068_bib0069","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209402","article-title":"Proportion of community-dwelling individuals older than 70 years eligible for Lecanemab initiation: the Gothenburg H70 birth cohort study","volume":"102","author":"Dittrich","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100068_bib0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp-2024-333468","article-title":"Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease","volume":"95","author":"Dobson","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100068_bib0077","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.2023.166","article-title":"Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK","volume":"224","author":"Laurell","year":"2024","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100068_bib0071","doi-asserted-by":"crossref","DOI":"10.1002\/alz.085900","article-title":"Estimating potential eligibility for disease modifying therapies for Alzheimer\u2019s disease using population-based data in Alberta, Canada","volume":"20","author":"Chowdhury","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.tjpad.2025.100068_bib0072","doi-asserted-by":"crossref","DOI":"10.1002\/alz.091118","article-title":"Potential eligibility for disease modifying therapies among individuals referred to a tertiary care memory clinic in Calgary, Alberta, Canada: implications for AD biomarker testing","volume":"20","author":"Thomas","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.tjpad.2025.100068_bib0067","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-160105","article-title":"Identification of physician-diagnosed Alzheimer's disease and related dementias in population-based administrative data: a validation study using family physicians' electronic medical records","volume":"54","author":"Jaakkimainen","year":"2016","journal-title":"J Alzheimer's Dis: JAD"},{"key":"10.1016\/j.tjpad.2025.100068_bib86","unstructured":"Armstrong J.J., Alzheimer Society of Canada. The Landmark Study: Navigating the path forward for dementia in Canada. Canada: Toronto: Alzheimer Society of. https:\/\/alzheimer.ca\/en\/research\/reports-dementia\/landmark-study-report-1-path-forward."},{"key":"10.1016\/j.tjpad.2025.100068_bib0073","first-page":"321","article-title":"Rural and urban Canadians with dementia: use of health care services","volume":"25","author":"Forbes","year":"2006","journal-title":"Can J aging = La revue canadienne du vieillissement"},{"key":"10.1016\/j.tjpad.2025.100068_bib0074","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073027","article-title":"Protocol for validating an algorithm to identify neurocognitive disorders in Canadian Longitudinal Study on Aging participants: an observational study","volume":"13","author":"Mayhew","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.tjpad.2025.100068_bib0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1017\/cjn.2019.27","article-title":"The comprehensive assessment of neurodegeneration and dementia: Canadian cohort study","volume":"46","author":"Chertkow","year":"2019","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.tjpad.2025.100068_bib0080","first-page":"1","article-title":"Canadian Medical Imaging Inventory 2022-2023: MRI","volume":"4","year":"2024","journal-title":"Can J Health Technol"},{"key":"10.1016\/j.tjpad.2025.100068_bib0081","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40120-023-00460-1","article-title":"Estimated societal value of Lecanemab in patients with early Alzheimer's disease using simulation modeling","volume":"12","author":"Tahami Monfared","year":"2023","journal-title":"Neurol Therapy"},{"key":"10.1016\/j.tjpad.2025.100068_bib0082","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s40120-023-00492-7","article-title":"Predicting the societal value of Lecanemab in early Alzheimer's Disease in Japan: a patient-level simulation","volume":"12","author":"Igarashi","year":"2023","journal-title":"Neurol Therapy"},{"key":"10.1016\/j.tjpad.2025.100068_bib0083","first-page":"1078","article-title":"The effectiveness and value of lecanemab for early Alzheimer disease: a summary from the Institute for clinical and economic review's California technology assessment forum","volume":"29","author":"Wright","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.tjpad.2025.100068_bib0084","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209218","article-title":"Cost-effectiveness of Lecanemab for individuals with early-stage Alzheimer disease","volume":"102","author":"Nguyen","year":"2024","journal-title":"Neurology"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:46:29Z","timestamp":1763336789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2274580725000123"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100068","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.18.24317292","asserted-by":"object"}]},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100068"}}